21st July 2021
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that Dr Anne Brindley has decided to step down as CEO. Anne will continue in her current position for the next six months and has committed to assist the Company with an orderly transition for that period. Download News